Evoq Remedies share news, announcements and annual reports
BSE: 543500Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹1.63.
30 Oct: open ₹1.63, high ₹1.63, low ₹1.63
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4.06 Cr4,812th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 8,000
Evoq Remedies share news and announcements
167 announcements, routine notices left out, newest first. Page 3 of 4.
Feb 2024
6 Feb · Meeting
3 Feb · Intimation And Outcome Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Jan 2024
16 Jan · Board meeting
Meeting on 22 Jan 2024: preferential issue of shares1 Jan · Legal
Exchange has sought clarification from Evoq Remedies Ltd on January 1, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Nov 2023
8 Nov · Board meeting
Meeting on 10 Nov 2023: half yearly results
Oct 2023
Sep 2023
11 Sep · Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
11 Sep · Management
11 Sep · Management
11 Sep · Board meeting
Jun 2023
May 2023
10 May · Board meeting
Meeting on 25 May 2023: audited results and half yearly results
Apr 2023
21 Apr · Subject: Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2023
11 Apr · Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2023
Mar 2023
Jan 2023
Nov 2022
Oct 2022
17 Oct · Board meeting
Meeting on 7 Nov 2022: rights issue of equity shares and half yearly results11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022